IP Library Granted Patent US 11,491,128
Granted Patent B2
US 11,491,128 · App. 16/995,594 · Granted Nov 8, 2022

Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions

Inventors: Marco Fazzari (Pittsburgh, PA); Bruce A. Freeman (Pittsburgh, PA); Francisco J. Schopfer (Pittsburgh, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
A61K31/201A61P1/04A61P3/00A61P3/04A61P9/08A61P13/12A61P29/00C07C57/02C07C205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,491,128
App. No.
16/995,594
Granted
Nov 8, 2022
Kind
B2
Abstract

Various embodiments of this invention are directed to pharmaceutical compositions and methods for treating disease. The compositions of such embodiments include reversible nitroxide derivatives of nitroalkenes. The methods of various embodiments include administering an effective amount of any of these pharmaceutical compositions to a patient in need of treatment.

Claims (11)

1. A compound of Formula I:

wherein R 1 is —NO 2 , R 2 is —ONO 2 , X 1 is —H; and X 2 is —COOH; and m and n are, independently, an integer from 1 to 10.

2. The compound of claim 1 , wherein the compound has a structure of:

3. A method of delivering nitric oxide comprising administering to a subject in need thereof an effective amount of the compound of claim 1 .

4. The method of claim 3 , wherein the compound has a structure of:

5. A method of treating inflammation, obesity, metabolic syndrome, acute kidney disease, or chronic kidney disease comprising administering to a subject in need thereof an effective amount of the compound of claim 1 .

6. The method of claim 5 , wherein negative side effects of a subject's gastrointestinal tract are reduced.

7. The method of claim 6 , wherein the side effects of the gastrointestinal tract is selected from the group consisting of diarrhea, cramping irritation, inflammatory bowel disease, colitis, and ulcers.

8. The method of claim 5 , wherein the compound has a structure of:

9. A method of inducing vasodilation comprising administering to a subject in need thereof an effective amount of the compound of claim 1 .

10. The method of claim 9 , wherein the compound has a structure of:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2020
From: FAZZARI, MARCO; FREEMAN, BRUCE A.; SCHOPFER, FRANCISCO JOSE
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 053541/0770 →
Continuity (3)
Continuation 16339703
Provisional Application 62404354 · Oct 5, 2016
Related Publication 20200375936A1 · Dec 3, 2020
Cited By (1)
US 12,728,111